Implications of coronary artery disease in heart failure with preserved ejection fraction

Journal of the American College of Cardiology

Volumn 63, Issue 25 PART A, 2014, Pages 2817-2827

  Hwang, Seok Jae ^a,b   Melenovsky, Vojtech ^a,c   Borlaug, Barry A ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b Gyeongsang National University   (South Korea)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

coronary artery disease; diastolic heart failure; heart failure; heart failure with preserved ejection fraction; revascularization

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT; NITRIC ACID DERIVATIVE; SODIUM;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY HEMODYNAMICS; DETERIORATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; ACUTE CORONARY SYNDROME; AGING; ARTERY COMPLIANCE; CORONARY VASCULAR RESISTANCE; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; DYSLIPIDEMIA; DYSPNEA; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE REVASCULARIZATION; HEART OUTPUT; HYPERTENSION; MORTALITY; PRESERVED EJECTION FRACTION; RISK FACTOR; SMOKING; SODIUM BLOOD LEVEL; SYMPTOM; SYNTAX SCORE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CORONARY ARTERY DISEASE; DIASTOLIC HEART FAILURE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; REVASCULARIZATION;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MINNESOTA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84903154515     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.034     Document Type: Article

References (27)

1. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
2. B.A. Borlaug, and W.J. Paulus Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Eur Heart J 32 2011 670 679
3. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
4. S.J. Shah, and M. Gheorghiade Heart failure with preserved ejection fraction: treat now by treating comorbidities JAMA 300 2008 431 433
5. S. Ather, W. Chan, and B. Bozkurt et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
6. S.J. Shah Matchmaking for the optimization of heart failure with preserved ejection fraction clinical trials: no laughing matter J Am Coll Cardiol 62 2013 1339 1342
7. O. Muller, and K. Rorvik Haemodynamic consequences of coronary heart disease with observations during anginal pain and on the effect of nitroglycerine Br Heart J 20 1958 302 310
8. T. Mann, S. Goldberg, G.H. Mudge Jr., and W. Grossman Factors contributing to altered left ventricular diastolic properties during angina pectoris Circulation 59 1979 14 20
9. T. Serizawa, W.M. Vogel, C.S. Apstein, and W. Grossman Comparison of acute alterations in left ventricular relaxation and diastolic chamber stiffness induced by hypoxia and ischemia. Role of myocardial oxygen supply-demand imbalance J Clin Invest 68 1981 91 102
10. D.A. Kass, M. Midei, J. Brinker, and W.L. Maughan Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans Circulation 81 1990 447 460
11. L. Choudhury, M. Gheorghiade, and R.O. Bonow Coronary artery disease in patients with heart failure and preserved systolic function Am J Cardiol 89 2002 719 722
12. B.A. Borlaug, T.P. Olson, and C.S. Lam et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction J Am Coll Cardiol 56 2010 845 854
13. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
14. G. Sianos, M.A. Morel, and A.P. Kappetein et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
15. P.W. Serruys, M.C. Morice, and A.P. Kappetein et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
16. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
17. S. Schwartzenberg, M.M. Redfield, A.M. From, P. Sorajja, R.A. Nishimura, and B.A. Borlaug Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy J Am Coll Cardiol 59 2012 442 451
18. M. Komajda, P.E. Carson, and S. Hetzel et al. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE) Circ Heart Fail 4 2011 27 35
19. C.S. Lam, E. Donal, E. Kraigher-Krainer, and R.S. Vasan Epidemiology and clinical course of heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 18 28
20. D.J. Kereiakes Complete revascularization: a quality-performance metric? J Am Coll Cardiol 62 2013 1432 1435
21. R.S. Bhatia, J.V. Tu, and D.S. Lee et al. Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
22. D.S. Lee, P. Gona, and R.S. Vasan et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute Circulation 119 2009 3070 3077
23. C. Tribouilloy, D. Rusinaru, and H. Mahjoub et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study Eur Heart J 29 2008 339 347
24. S.M. Dunlay, V.L. Roger, S.A. Weston, R. Jiang, and M.M. Redfield Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction Circ Heart Fail 5 2012 720 726
25. K.W. Judge, Y. Pawitan, J. Caldwell, B.J. Gersh, and J.W. Kennedy Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry J Am Coll Cardiol 18 1991 377 382
26. G.M. Felker, L.K. Shaw, and C.M. O'Connor A standardized definition of ischemic cardiomyopathy for use in clinical research J Am Coll Cardiol 39 2002 210 218
27. K. Kramer, P. Kirkman, D. Kitzman, and W.C. Little Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization Am Heart J 140 2000 451 455